224 related articles for article (PubMed ID: 16172484)
21. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
22. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Skiest DJ; Hester LJ; Hardy RD
J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
[TBL] [Abstract][Full Text] [Related]
23. Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population.
Cunha VS; Zampese MS; Aquino VR; Cestari TF; Goldani LZ
Clin Exp Dermatol; 2007 May; 32(3):250-5. PubMed ID: 17397349
[TBL] [Abstract][Full Text] [Related]
24. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
26. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
27. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
28. Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis.
Koo HL; Hamill RJ; Andrade RA
Clin Infect Dis; 2007 Sep; 45(6):e77-9. PubMed ID: 17712747
[TBL] [Abstract][Full Text] [Related]
29. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
Chan KC; Wong KH; Lee SS
HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
[TBL] [Abstract][Full Text] [Related]
30. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
[TBL] [Abstract][Full Text] [Related]
31. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART.
Chaiwarith R; Charoenyos N; Sirisanthana T; Supparatpinyo K
AIDS; 2007 Jan; 21(3):365-7. PubMed ID: 17255744
[TBL] [Abstract][Full Text] [Related]
32. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
[TBL] [Abstract][Full Text] [Related]
33. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
Yang YL; Lo HJ; Hung CC; Li Y
BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
[TBL] [Abstract][Full Text] [Related]
34. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
[TBL] [Abstract][Full Text] [Related]
35. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
[TBL] [Abstract][Full Text] [Related]
36. Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
Verweel G; Saavedra-Lozano J; van Rossum AM; Ramilo O; de Groot R
Pediatr Infect Dis J; 2006 Nov; 25(11):987-94. PubMed ID: 17072119
[TBL] [Abstract][Full Text] [Related]
37. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
39. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
[TBL] [Abstract][Full Text] [Related]
40. Disseminated cutaneous histoplasmosis in acquired immunodeficiency syndrome: report of 23 cases.
Bonifaz A; Chang P; Moreno K; Fernández-Fernández V; Montes de Oca G; Araiza J; Ponce RM
Clin Exp Dermatol; 2009 Jun; 34(4):481-6. PubMed ID: 19040507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
